These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 20649179)
21. High expression of hTERT and stemness genes in BORIS/CTCFL positive cells isolated from embryonic cancer cells. Alberti L; Renaud S; Losi L; Leyvraz S; Benhattar J PLoS One; 2014; 9(10):e109921. PubMed ID: 25279549 [TBL] [Abstract][Full Text] [Related]
22. Promoter hypomethylation and reactivation of MAGE-A1 and MAGE-A3 genes in colorectal cancer cell lines and cancer tissues. Kim KH; Choi JS; Kim IJ; Ku JL; Park JG World J Gastroenterol; 2006 Sep; 12(35):5651-7. PubMed ID: 17007017 [TBL] [Abstract][Full Text] [Related]
23. DNA methylation and nucleosome occupancy regulate the cancer germline antigen gene MAGEA11. James SR; Cedeno CD; Sharma A; Zhang W; Mohler JL; Odunsi K; Wilson EM; Karpf AR Epigenetics; 2013 Aug; 8(8):849-63. PubMed ID: 23839233 [TBL] [Abstract][Full Text] [Related]
24. The epigenetic factor BORIS/CTCFL regulates the NOTCH3 gene expression in cancer cells. Zampieri M; Ciccarone F; Palermo R; Cialfi S; Passananti C; Chiaretti S; Nocchia D; Talora C; Screpanti I; Caiafa P Biochim Biophys Acta; 2014 Sep; 1839(9):813-25. PubMed ID: 24984200 [TBL] [Abstract][Full Text] [Related]
25. Expression of GBGT1 is epigenetically regulated by DNA methylation in ovarian cancer cells. Jacob F; Hitchins MP; Fedier A; Brennan K; Nixdorf S; Hacker NF; Ward R; Heinzelmann-Schwarz VA BMC Mol Biol; 2014 Oct; 15():24. PubMed ID: 25294702 [TBL] [Abstract][Full Text] [Related]
26. DNA hypomethylation-mediated overexpression of carbonic anhydrase 9 induces an aggressive phenotype in ovarian cancer cells. Sung HY; Ju W; Ahn JH Yonsei Med J; 2014 Nov; 55(6):1656-63. PubMed ID: 25323905 [TBL] [Abstract][Full Text] [Related]
27. Differential regulation of MAGE-A1 promoter activity by BORIS and Sp1, both interacting with the TATA binding protein. Schwarzenbach H; Eichelser C; Steinbach B; Tadewaldt J; Pantel K; Lobanenkov V; Loukinov D BMC Cancer; 2014 Nov; 14():796. PubMed ID: 25363021 [TBL] [Abstract][Full Text] [Related]
28. Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy. Srivastava P; Paluch BE; Matsuzaki J; James SR; Collamat-Lai G; Blagitko-Dorfs N; Ford LA; Naqash R; Lübbert M; Karpf AR; Nemeth MJ; Griffiths EA Oncotarget; 2016 Mar; 7(11):12840-56. PubMed ID: 26883197 [TBL] [Abstract][Full Text] [Related]
29. A novel cancer/testis antigen KP-OVA-52 identified by SEREX in human ovarian cancer is regulated by DNA methylation. Kim KM; Song MH; Kim MJ; Daudi S; Miliotto A; Old L; Odunsi K; Lee SY Int J Oncol; 2012 Sep; 41(3):1139-47. PubMed ID: 22684412 [TBL] [Abstract][Full Text] [Related]
30. Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo. Steele N; Finn P; Brown R; Plumb JA Br J Cancer; 2009 Mar; 100(5):758-63. PubMed ID: 19259094 [TBL] [Abstract][Full Text] [Related]
31. BORIS binding to the promoters of cancer testis antigens, MAGEA2, MAGEA3, and MAGEA4, is associated with their transcriptional activation in lung cancer. Bhan S; Negi SS; Shao C; Glazer CA; Chuang A; Gaykalova DA; Sun W; Sidransky D; Ha PK; Califano JA Clin Cancer Res; 2011 Jul; 17(13):4267-76. PubMed ID: 21558405 [TBL] [Abstract][Full Text] [Related]
32. Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway. Wang Z; Li M; Lu S; Zhang Y; Wang H Cancer Biol Ther; 2006 Mar; 5(3):256-60. PubMed ID: 16418574 [TBL] [Abstract][Full Text] [Related]
33. Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma. Shi X; Chen X; Fang B; Ping Y; Qin G; Yue D; Li F; Yang S; Zhang Y Biomed Pharmacother; 2019 Apr; 112():108632. PubMed ID: 30797153 [TBL] [Abstract][Full Text] [Related]
34. BORIS in human cancers -- a review. Martin-Kleiner I Eur J Cancer; 2012 Apr; 48(6):929-35. PubMed ID: 22019212 [TBL] [Abstract][Full Text] [Related]
35. The DNA demethylating agent 5-aza-2'-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells. Almstedt M; Blagitko-Dorfs N; Duque-Afonso J; Karbach J; Pfeifer D; Jäger E; Lübbert M Leuk Res; 2010 Jul; 34(7):899-905. PubMed ID: 20381863 [TBL] [Abstract][Full Text] [Related]
36. Dynamic transcriptional regulatory complexes including BORIS, CTCF and Sp1 modulate NY-ESO-1 expression in lung cancer cells. Kang Y; Hong JA; Chen GA; Nguyen DM; Schrump DS Oncogene; 2007 Jun; 26(30):4394-403. PubMed ID: 17260018 [TBL] [Abstract][Full Text] [Related]
37. Expression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factors. Renaud S; Pugacheva EM; Delgado MD; Braunschweig R; Abdullaev Z; Loukinov D; Benhattar J; Lobanenkov V Nucleic Acids Res; 2007; 35(21):7372-88. PubMed ID: 17962299 [TBL] [Abstract][Full Text] [Related]
38. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma. Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312 [TBL] [Abstract][Full Text] [Related]
39. Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer. Sheng X; Li J; Yang L; Chen Z; Zhao Q; Tan L; Zhou Y; Li J Oncol Rep; 2014 Jul; 32(1):277-85. PubMed ID: 24859196 [TBL] [Abstract][Full Text] [Related]